IM Therapeutics, Inc.;The Regents of the University of Colorado, a body corporate
发明人:
Steve Orndorff,Aaron Michels,Peter Gottlieb
申请号：
US15466026
公开号：
US20170273927A1
申请日:
2017.03.22
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Methods of treating, ameliorating, or inhibiting the development of autoimmune diseases by modulating the binding of MHC class II molecules to antigenic peptides or fragments of antigenic peptides of the autoimmune disease. The binding may be modulated by the administration of D-α-methyldopa, or pharmaceutical compositions comprising therapeutically effective amounts of D-α-methyldopa.
